GoodRx Corp (GDRX) - Rasio Kapitalisasi Pasar marang Nilai Buku

Tandha merek GoodRx Corp (GDRX)

The efficiency of the GoodRx Holdings, Inc. (GDRX) platform relies on the volume of its solvent audience and payments from insurance intermediaries, with the key metric standing at 1.84. This chart of the market trend in monetary terms demonstrates the asset's price action. Management is currently striving to restore shareholder loyalty by implementing additional tools for pharmaceutical brands to expand profit sources and maintain its position in the discount sector.

GDRX: Multiplikator Kapitalisasi Pasar marang Nilai Buku goodrx.com 04.07.2022 - 30.10.2026
Produk asil prodhuksi GoodRx Inc

Investors use this ratio to assess the market premium over net assets, determining the extent to which shares are overvalued relative to book capital. By analyzing the current ratio of GoodRx Holdings, Inc. (GDRX) market value to its book capitalization, one can understand the degree to which the market values the cloud IT infrastructure of GoodRx Holdings, Inc. (GDRX)—which integrated pharmacy databases to ensure drug pricing transparency—above its formal tangible assets.

Pesaing wigati

VEEV (Veeva Systems Inc.) - Rasio Kapitalisasi marang Aset Bersih|Rasio Kapitalisasi marang Nilai Buku DOCS|HQY (HealthEquity) - Rasio Kapitalisasi Pasar marang Nilai Buku|Waystar Health (WAY) - Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih CRVL (CorVel Healthcare)|Multiplikator Kapitalisasi Pasar marang Nilai Buku PRVA|Huron Consulting Group - Rasio Kapitalisasi marang Aset Bersih|Nilai Pasar marang Nilai Buku CERT|OMCL - Rasio Nilai Pasar marang Nilai Buku|Schrodinger Inc (SDGR) - Rasio Kapitalisasi marang Aset Bersih|PHR: Rasio Kapitalisasi Pasar marang Nilai Buku|Koefisien Nilai Pasar marang Nilai Buku Omada (OMDA)|EVH (Evolent Health, Inc.) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi marang Nilai Buku HSTM (healthstream.com)|Rasio Kapitalisasi Pasar marang Nilai Buku DH|Consensus Cloud Solutions Inc (CCSI) - Rasio Nilai Pasar marang Ekuitas|Rasio Nilai Pasar marang Nilai Buku agilon health Inc AGL|Absci Bio (ABSI) - Koefisien Nilai Pasar marang Nilai Buku|SY - Rasio Nilai Pasar marang Nilai Buku|Koefisien Nilai Pasar marang Nilai Buku National Research Corp|SPOK: Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi marang Nilai Buku OPRX|Rasio Nilai Pasar marang Nilai Buku CPSI|SLP: Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih SOPH (SOPHiA GENETICS SA)|healthcatalyst.com - Rasio Kapitalisasi marang Nilai Buku|CareCloud - Rasio Kapitalisasi marang Aset Bersih|Nilai Pasar marang Nilai Buku RSSS|DLH Holdings Corp - Rasio Kapitalisasi Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku ONMD (OneMedNet Corporation)|Scienture Holdings Inc (SCNX) - Rasio Nilai Pasar marang Nilai Buku|Koefisien Nilai Pasar marang Nilai Buku healthcaretriangle.com (HCTI)|Rasio Nilai Pasar marang Nilai Buku iSpecimen Inc|Rasio Nilai Pasar marang Nilai Buku BFRG|Rasio Kapitalisasi Pasar marang Nilai Buku WORX|MSP Recovery Corp - Rasio Kapitalisasi marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku ICCT (iCoreConnect)|Kapitalisasi Pasar marang Nilai Buku trxadehealth.com (MEDS)|ORGS - Rasio Nilai Pasar marang Nilai Buku|RCM (R1 RCM Inc.) - Rasio Kapitalisasi marang Nilai Buku|SHCR: Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Ekuitas Streamline Health, Inc. STRM|Rasio Nilai Pasar marang Nilai Buku Syra Health Corp.|ApolloMed (AMEH) - Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih MODN (Model N)|NXGN (NextGen Healthcare Inc) - Nilai Pasar marang Nilai Buku